You are hereBlogs / Ian Dettman's blog
Ian Dettman's blog
Dettman I, Meakin C, Allen R; Co-infusing Glutathione and Vitamin C during cancer treatment: A reply. ACNEM Journal, Mar 2012, Vol 31 No. 1 p 8-11
This article is a great review of the author's understanding of the role of adjunctive treatments at end of life.
Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda Massari JR, Alexandrescu DT, Dasanu C, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 4;9(1):25. [Epub ahead of print] PubMed PMID: 21375761
The Japanese College of Intravenous Therapy, headed by Dr Atsuo Yanagisawa, recently held a meeting for Doctors on the topic of “Intravenous Vitamin C and Cancer”. Several notable Japanese and o/seas researchers presented some leading edge research – included Dr Steve Hickey author of “Ascorbate –the science of Vitamin C” who was accompanied by the co-author Dr Hilary Roberts, Dr Ron Hunninghake leading researcher at the Riordan Clinic and Dr John Hoffer (Dr Abram Hoffers’s son) also a leading researcher in IVC and cancer.
Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: RCT
An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administration of B vitamins.
Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer
The aim of this study was to test for the influence of ascorbic acid on tumorigenicity and metastases of implanted PAIII prostate cancer adenocarcinoma cells in syngeneic LW rats.
MATERIALS AND METHODS:
The following is a link to the NZ TV program about the farmer who recovered from swine flu because the doctors in the hospital turned him into a prone position (and he was incidentally on high-dose IV C):
A recent report AGAIN in JAMA (i) has highlighted a potential problem with very high dose oral folate along with B6 and B12 in people with diabetic nephropathy - “A multicenter, randomized, double-blind, placebo controlled trial (Diabetic Intervention with Vitamins to Improve Nephropathy [DIVINe]) at 5 university medical centers in Canada conducted between May 2001 and July 2007 of 238 participants who had type 1 or 2 diabetes and a clinical diagnosis of diabetic nephropathy.”
A recent report in JAMA (i) has highlighted a potential problem with very high dose oral cholecalciferol in elderly people - “A double-blind, placebo-controlled trial of 2256 community-dwelling women, aged 70 years or older, considered to be at high risk of fracture were recruited from June 2003 to June 2005 and were randomly assigned to receive cholecalciferol or placebo each autumn to winter for 3 to 5 years. The study concluded in 2008.”
Access to Parenteral Thiamine
Biological Therapies has a registered 100 mg in 1 mL Thiamine Hydrochloride injection in a box of 10 vials with a shelf life of 12 months.
Biological Therapies also supplies a range of registered B-complex injections containing parenteral thiamine.